Phototherapy in Persons With Multiple Sclerosis
Effect of UVB Phototherapy on Serum Vitamin D in Persons With Multiple Sclerosis; a Placebo Controlled Study
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Phototherapy
What it measured
Main measures
Change from Baseline in Serum Vitamin D at 4 and 8 weeks
0, 4, and 8 weeks
Other measures (3)
Change from Baseline in Walking Speed at 4 and 8 weeks
0, 4, and 8 weeks
Walking and mobilityChange from Baseline in Cognitive Function at 4 and 8 weeks
0, 4, and 8 weeks
Thinking and memoryChange from Baseline in Mood State at 4 and 8 weeks
0, 4, and 8 weeks
Mood and sleep
Who could take part
MS (type not specified) · 18 to 64
Show the full criteria
Inclusion criteria
* Female with multiple sclerosis
Exclusion criteria
* Inability to stand still in a stabilized fashion without risk of falling for up to 6 minutes * Known medical history of calcium disorder or knowledge of high calcium levels * Known medical history of hyper-parathyroidism * Current supplementation with oral vitamin D * Known allergy to vitamin D * History of cancer of any type including but not limited to skin cancer * Obesity defined as BMI > 30 * Known history of fat malabsorption conditions (i.e., steatorrhea) * Current use of anti-epileptic medication * Current use of glucocorticoids * Fitzpatrick skin types I and VI using the Fitzpatrick skin type analysis * Recent use of tanning facilities
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The current study examines the effect of phototherapy equipped with Narrow Band UVB lamps on vitamin D production in persons with MS.
Loading reviews and guidelines…
History
Started
Jan 2015
Main results due
Feb 2016
Finished
Feb 2016